Novo Nordisk A/S ( NVO) - Stock Earnings
NVO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 20.0 billion USD | 75.0 billion USD |
| 2025Q4 | 26.9 billion USD | 79.1 billion USD |
| 2026Q1 | 48.6 billion USD | 96.8 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NVO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 83.7 billion USD | 232.3 billion USD |
| 2024 | 101.0 billion USD | 290.4 billion USD |
| 2025 | 102.4 billion USD | 309.1 billion USD |
| 2026 Est. | — | — |
NVO
Price: $43.88
Dividend Yield: 4.28%
Forward Dividend Yield: 5.81%
Payout Ratio: 24.32%
Dividend Per Share: 2.55 USD
Earnings Per Share: 4.30 USD
P/E Ratio: 10.79
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Volume: 1.1 million
Ebitda: 1.9 billionMarket Capitalization: 186.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 45
DGR3: 29.57%
DGR5: 22.96%
DGR10: 20.32%
DGR20: 22.69%